InnovAge Stock Price, News & Analysis (OTCMKTS:INNV) $5.76 -0.04 (-0.69%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$5.64▼$6.1050-Day Range$5.18▼$7.0152-Week Range$5.04▼$8.15Volume15,077 shsAverage Volume36,219 shsMarket Capitalization$782.70 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings InnovAge MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside38.9% Upside$8.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.25) to ($0.05) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.46 out of 5 stars 3.0 Analyst's Opinion Consensus RatingInnovAge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.00, InnovAge has a forecasted upside of 38.9% from its current price of $5.76.Amount of Analyst CoverageInnovAge has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for INNV. Previous Next 0.0 Dividend Strength Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INNV. Previous Next 1.4 News and Social Media Coverage News SentimentInnovAge has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Medical companies. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.41% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.17% of the stock of InnovAge is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for InnovAge are expected to grow in the coming year, from ($0.25) to ($0.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -18.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -18.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 2.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About InnovAge Stock (OTCMKTS:INNV)InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More INNV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INNV Stock News HeadlinesNovember 22, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) and InnovAge (OTCMKTS:INNV) Critical SurveyNovember 7, 2023 | finance.yahoo.comInnovAge Announces Financial Results For The Fiscal First Quarter Ended September 30, 2023November 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 13, 2023 | finance.yahoo.comInnovAge Holding Corp. (NASDAQ:INNV) Q4 2023 Earnings Call TranscriptSeptember 11, 2023 | benzinga.comEarnings Preview: InnovAge HoldingSeptember 10, 2023 | msn.comDow futures trade flat, fresh inflation data in focusSeptember 10, 2023 | msn.comINNVInnovAge Holding Corp.August 29, 2023 | finance.yahoo.comInnovAge to Announce Fiscal Fourth Quarter 2023 Financial Results and Host Conference Call Tuesday, September 12, 2023November 29, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!August 16, 2023 | benzinga.comPerformance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On WednesdayAugust 14, 2023 | finance.yahoo.comInnovAge Strengthens Board with Appointment of New Independent DirectorJuly 6, 2023 | bizjournals.comInnovAge taps former health care investment banker for newly vacated CFO roleJuly 5, 2023 | finance.yahoo.comInnovAge Names Ben Adams as New Chief Financial OfficerJuly 5, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of InnovAge Holding Corp. (NASDAQ:INNV)June 27, 2023 | msn.comInnovAge Holding: EBITDA In Focus With No More SanctionsJune 16, 2023 | msn.comInnovAge Holding: Gross Productivity, Multiples Speak VolumesJune 8, 2023 | finance.yahoo.comInnovAge Holding (NASDAQ:INNV) soars 17% this week, taking one-year gains to 48%June 5, 2023 | finance.yahoo.comInnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare ConferenceMay 11, 2023 | msn.comRecap: InnovAge Holding Q3 EarningsMay 11, 2023 | finance.yahoo.comInnovAge Holding Third Quarter 2023 Earnings: EPS Misses ExpectationsMay 10, 2023 | bizjournals.comInnovAge points to small but steady signs of growth after release from final sanctionsMay 10, 2023 | finance.yahoo.comInnovAge Holding Corp. (INNV) Reports Q3 Loss, Lags Revenue EstimatesMay 9, 2023 | finance.yahoo.comInnovAge Announces Financial Results For The Fiscal Third Quarter Ended March 31, 2023May 8, 2023 | markets.businessinsider.comWhat Wall Street expects from InnovAge's earningsMay 1, 2023 | finance.yahoo.comFinal Sanction Removed at InnovAge Sacramento PACE Center Enabling New Participant EnrollmentApril 25, 2023 | finance.yahoo.comInnovAge to Announce Fiscal Third Quarter 2023 Financial Results and Host Conference Call Tuesday, May 9, 2023April 17, 2023 | finance.yahoo.comNot Many Are Piling Into InnovAge Holding Corp. (NASDAQ:INNV) Just YetSee More Headlines Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/07/2023Today11/29/2023Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Care Facilities Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:INNV Previous SymbolNASDAQ:INNV CUSIPN/A CIK1411879 Webwww.innovuspharma.com Phone844-803-8745FaxN/AEmployees2,100Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$9.00 Low Stock Price Target$7.00 Potential Upside/Downside+38.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,520,000.00 Net Margins-6.17% Pretax Margin-7.63% Return on Equity-13.04% Return on Assets-7.48% Debt Debt-to-Equity Ratio0.25 Current Ratio1.57 Quick Ratio1.57 Sales & Book Value Annual Sales$699.35 million Price / Sales1.12 Cash Flow$0.09 per share Price / Cash Flow65.41 Book Value$2.50 per share Price / Book2.30Miscellaneous Outstanding Shares135,885,000Free Float135,311,000Market Cap$782.70 million OptionableNot Optionable Beta0.09 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Patrick Blair (Age 52)President & CEO Comp: $1.51MMs. Nicole D'Amato (Age 44)Chief Legal Officer & Corporate Secretary Comp: $678.76kDr. Richard A. Feifer FACP (Age 56)M.D., M.P.H., Chief Medical Officer Comp: $588.97kMr. Edward Moore Kennedy Jr. (Age 62)J.D., Independent Director Comp: $100kHon. Marilyn Barbour Tavenner M.H.A. (Age 62)R.N., Independent Director Comp: $120kMr. Benjamin Crowninshield Adams (Age 59)Chief Financial Officer Ms. Christine Bent (Age 53)Chief Operations Officer Ms. Cara BabachicosChief Information OfficerMr. Ryan KubotaDirector of Investor RelationsMs. Olivia PattonChief Compliance OfficerMore ExecutivesKey CompetitorsEnhabitNYSE:EHABPharming GroupNASDAQ:PHARValnevaNASDAQ:VALNVarex ImagingNASDAQ:VREXIntercept PharmaceuticalsNASDAQ:ICPTView All CompetitorsInsidersNicole DamatoSold 1,866 sharesTotal: $13,192.62 ($7.07/share)Nicole DamatoSold 411 sharesTotal: $2,909.88 ($7.08/share)Nicole DamatoSold 6,422 sharesTotal: $45,596.20 ($7.10/share)Nicole DamatoSold 4,173 sharesTotal: $30,379.44 ($7.28/share)Nicole DamatoSold 2,101 sharesTotal: $15,253.26 ($7.26/share)View All Insider Transactions INNV Stock Analysis - Frequently Asked Questions Should I buy or sell InnovAge stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares. View INNV analyst ratings or view top-rated stocks. What is InnovAge's stock price target for 2024? 2 analysts have issued 1 year target prices for InnovAge's stock. Their INNV share price targets range from $7.00 to $9.00. On average, they anticipate the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 38.9% from the stock's current price. View analysts price targets for INNV or view top-rated stocks among Wall Street analysts. How have INNV shares performed in 2023? InnovAge's stock was trading at $7.18 at the start of the year. Since then, INNV shares have decreased by 19.8% and is now trading at $5.76. View the best growth stocks for 2023 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (OTCMKTS:INNV) issued its quarterly earnings results on Tuesday, November, 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.04. The company had revenue of $182.49 million for the quarter, compared to analysts' expectations of $176.81 million. InnovAge had a negative trailing twelve-month return on equity of 13.04% and a negative net margin of 6.17%. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some companies that other InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Federal National Mortgage Association (FNMA), Medicines (MDCO), Frontier Communications (FTR), FedEx (FDX), Republic First Bancorp (FRBK), Aytu BioPharma (AYTU), NVIDIA (NVDA) and Pacific Premier Bancorp (PPBI). How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:INNV) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.